Shi Hao,Lyu Zhibao,Chen Zhou.Laparoscopic-assisted doxycycline injection for giant retroperitoneal lymphatic malformation[J].Journal of Clinical Pediatric Surgery,,22():1178-1183.[doi:10.3760/cma.j.cn101785-202202006-015]
Laparoscopic-assisted doxycycline injection for giant retroperitoneal lymphatic malformation
- Keywords:
- Lymphatic Abnormalities; Retroperitoneal Space; Laparoscopy; Doxycycline; Injections; Intralesional; Treatment Outcome
- Abstract:
- Objective To explore the application of laparoscopic-assisted sclerotherapy for giant retroperitoneal lymphatic malformation (rLM).Methods From July 2020 to July 2021,retrospective review was conducted for clinical data of 3 children with giant retroperitoneal lymphatic malformation receiving laparoscopic-assisted doxycycline injection.And the relevant literature was retrived for discuss the approaches of injection therapy,efficacy and cautions.Results There were 1 boy and 2 girls with an age range of (26-68) month.Two cases presented with abdominal pain and inguinal masses.A total of 5 injections were performed and 2 cases treated twice.In case No.1,the maximal diameter of lesion decreased from 14.7 to 4.0 cm after treatment with a volume reduction of 95.2%; In case No.2,the maximal diameter of lesion dropped from 11.8 to 5.5 cm after treatment with a volume reduction of 95%; In case No.3,the maximal diameter of lesion declined from 9.0 to 2.5 cm after treatment with a volume reduction of 98.9%.All of them reached the standard of cure and the symptoms disappeared.Only one case of postoperative vomiting resolved spontaneously.No recurrence or other complications were observed during a follow-up period of (6-12) months.Conclusions Sclerotherapy injection for gaint retroperitoneal lymphatic malformation has a marked efficacy and a high safety.And laparoscopic assistance may offer minimal invasion,improve accuracy of injection and reduce complications.
References:
[1] Kalwani NM,Rockson SG.Management of lymphatic vascular malformations:a systematic review of the literature[J].J Vasc Surg Venous Lymphat Disord,2021,9(4):1077-1082.DOI:10.1016/j.jvsv.2021.01.013.
[2] Wohlgemuth WA,Brill R,Dendl LM,et al.Abdominal lymphatic malformations[J].Radiologe,2018,58(Suppl 1):29-33.DOI:10.1007/s00117-017-0337-5.
[3] Defnet AM,Bagrodia N,Hernandez SL,et al.Pediatric lymphatic malformations:evolving understanding and therapeutic options[J].Pediatr Surg Int,2016,32(5):425-433.DOI:10.1007/s00383-016-3867-4.
[4] Bouwman FCM,Kooijman SS,Verhoeven BH,et al.Lymphatic malformations in children:treatment outcomes of sclerotherapy in a large cohort[J].Eur J Pediatr,2021,180(3):959-966.DOI:10.1007/s00431-020-03811-4.
[5] Kim SH,Kim HY,Lee C,et al.Clinical features of mesenteric lymphatic malformation in children[J].J Pediatr Surg,2016,51(4):582-587.DOI:10.1016/j.jpedsurg.2015.11.021.
[6] Zamora AK,Barry WE,Nowicki D,et al.A multidisciplinary approach to management of abdominal lymphatic malformations[J].J Pediatr Surg,2021,56(8):1425-1429.DOI:10.1016/j.jpedsurg.2020.10.007.
[7] Kawamoto A,Inoue M,Uchida K,et al.A huge lymphovenous malformation in the retroperitoneum[J].J Pediatr Surg,2008,43(2):e21-e25.DOI:10.1016/j.jpedsurg.2007.11.002.
[8] Hathaway BA,Radu S,Wilson J,et al.Lymphatic and mixed malformations[J].Lymphat Res Biol,2021,19(1):41-50.DOI:10.1089/lrb.2020.0100.
[9] Elbaaly H,Piché N,Rypens F,et al.Intra-abdominal lymphatic malformation management in light of the updated International Society for the Study of Vascular Anomalies classification[J].Pediatr Radiol,2021,51(5):760-772.DOI:10.1007/s00247-020-04930-8.
[10] Silvaroli S,Merli L,Paradiso FV,et al.Video assisted sclerosis of endoabdominal lymphangiomas with OK432:an effective,safe and minimally invasive choice[J].J Pediatr Surg Case Rep,2021,67:101816.DOI:10.1016/j.epsc.2021.101816.
[11] Madsen HJ,Annam A,Harned R,et al.Symptom resolution and volumetric reduction of abdominal lymphatic malformations with sclerotherapy[J].J Surg Res,2019,233:256-261.DOI:10.1016/j.jss.2018.07.031.
[12] Kulungowski AM,Patel M.Lymphatic malformations[J].Semin Pediatr Surg,2020,29(5):150971.DOI:10.1016/j.sempedsurg.2020.150971.
[13] Hashimoto N,Phan SH,Imaizumi K,et al.Endothelial-mesenchymal transition in bleomycin-induced pulmonary fibrosis[J].Am J Respir Cell Mol Biol,2010,43(2):161-172.DOI:10.1165/rcmb.2009-0031OC.
[14] Y?lmaz H,Y?lmaz ?,?amL?da? ?,et al.Single center experience with intralesional bleomycin sclerotherapy for lymphatic malformations[J].Jpn J Radiol,2017,35(10):590-596.DOI:10.1007/s11604-017-0672-5.
[15] Sheng LL,Yu ZY,Li SL,et al.Bleomycin sclerotherapy for large diffuse microcystic lymphatic malformations[J].Gland Surg,2021,10(6):1865-1873.DOI:10.21037/gs-21-70.
[16] Méndez-Echevarría A,Fernandez-Prieto A,de la Serna O,et al.Acute lung toxicity after intralesional bleomycin sclerotherapy[J].Pediatrics,2018,141(1):e20161787.DOI:10.1542/peds.2016-1787.
[17] Khera D,Bhatnagar A,Khera PS,et al.Percutaneous sclerotherapy of superficial vascular malformation leading to bleomycin induced lung injury and lipoid pneumonia[J].Indian J Pediatr,2019,86(1):97-98.DOI:10.1007/s12098-018-2718-9.
[18] Cho AL,Kiang SC,Lodenkamp J,et al.Fatal lung toxicity after intralesional bleomycin sclerotherapy of a vascular malformation[J].Cardiovasc Intervent Radiol,2020,43(4):648-651.DOI:10.1007/s00270-020-02420-w.
[19] Markovic JN,Nag U,Shortell CK.Safety and efficacy of foam sclerotherapy for treatment of low-flow vascular malformations in children[J].J Vasc Surg Venous Lymphat Disord,2020,8(6):1074-1082.DOI:10.1016/j.jvsv.2019.11.023.
[20] 刘雅榕,李响,林栋盛,等.B超引导下多点注射聚桂醇治疗头颈部淋巴管畸形[J].中国美容医学,2019,28(5):36-39.DOI:10.15909/j.cnki.cn61-1347/r.003025. Liu YR,Li X,Lin DS,et al.Multi-point injection lauromacrogol foam sclerotherapy guided by ultrasound for lymphatic malformations in heads and necks[J].Chin J Aesthet Med,2019,28(5):36-39.DOI:10.15909/j.cnki.cn61-1347/r.003025.
[21] 中华口腔医学会口腔颌面外科专业委员会脉管性疾病学组.聚桂醇硬化剂治疗口腔颌面部血管瘤和脉管畸形专家共识[J].中国口腔颌面外科杂志,2018,16(3):275-278.DOI:10.19438/j.cjoms.2018.03.017. Group of Vascular Disease,Specialty Committee of Oral and Maxillofacial Surgery,Chinese Association of Oral Medicine:Expert Consensus on the Treatment of Oral and Maxillofacial Hemangiomas and Vascular Malformations by Lauromacrogol Sclerotherapy[J].China J Oral Maxillofac Surg,2018,16(3):275-278.DOI:10.19438/j.cjoms.2018.03.017.
[22] Thomas DM,Wieck MM,Grant CN,et al.Doxycycline sclerotherapy is superior in the treatment of pediatric lymphatic malformations[J].J Vasc Interv Radiol,2016,27(12):1846-1856.DOI:10.1016/j.jvir.2016.08.012.
[23] De Maria L,De Sanctis P,Balakrishnan K,et al.Sclerotherapy for lymphatic malformations of head and neck:systematic review and meta-analysis[J].J Vasc Surg Venous Lymphat Disord,2020,8(1):154-164.DOI:10.1016/j.jvsv.2019.09.007.
[24] Motz KM,Nickley KB,Bedwell JR,et al.OK432 versus doxycycline for treatment of macrocystic lymphatic malformations[J].Ann Otol Rhinol Laryngol,2014,123(2):81-88.DOI:10.1177/0003489414523561.
[25] Lee CZ,Xu B,Hashimoto T,et al.Doxycycline suppresses cerebral matrix metalloproteinase-9 and angiogenesis induced by focal hyperstimulation of vascular endothelial growth factor in a mouse model[J].Stroke,2004,35(7):1715-1719.DOI:10.1161/01.STR.0000129334.05181.b6.
[26] Stultz JS,Eiland LS.Doxycycline and tooth discoloration in children:changing of recommendations based on evidence of safety[J].Ann Pharmacother,2019,53(11):1162-1166.DOI:10.1177/1060028019863796.
[27] P?yh?nen H,Nurmi M,Peltola V,et al.Dental staining after doxycycline use in children[J].J Antimicrob Chemother,2017,72(10):2887-2890.DOI:10.1093/jac/dkx245.
[28] Russell KW,Rollins MD,Feola GP,et al.Sclerotherapy for intra-abdominal lymphatic malformations in children[J].Eur J Pediatr Surg,2014,24(4):317-321.DOI:10.1055/s-0033-1349058.
[29] 谢民,宁金波,姚明木,等.囊内出血对儿童大囊型淋巴管畸形硬化治疗效果的影响[J].临床小儿外科杂志,2021,20(1):65-68.DOI:10.12260/lcxewkzz.2021.01.013. Xie M,Ning JB,Yao MM,et al.Effect of hemorrhage of large cystic lymphatic malformation on therapeutic efficacy of sclerotherapy in children[J].J Clin Ped Sur,2021,20(1):65-68.DOI:10.12260/lcxewkzz.2021.01.013.
Memo
收稿日期:2022-2-6。
基金项目:上海市儿童医院院级课题临床研究培育面上项目(2020YLYM02)
通讯作者:陈舟,Email:chenz@shchildren.com.cn